Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer

Significant advancements have been made in recent years in advanced breast cancer and nearly all of them have been in the field of targeted therapy. Pertuzumab and trastuzumab-emtansine (T-DM1) have been able to be introduced in HER2-positive breast cancer. Now other anti-HER2 therapies are being de...

Descripción completa

Detalles Bibliográficos
Autores principales: Welslau, Manfred, Hartkopf, Andreas D., Müller, Volkmar, Wöckel, Achim, Lux, Michael P., Janni, Wolfgang, Ettl, Johannes, Lüftner, Diana, Belleville, Erik, Schütz, Florian, Fasching, Peter A., Kolberg, Hans-Christian, Nabieva, Naiba, Overkamp, Friedrich, Taran, Florin-Andrei, Brucker, Sara Y., Wallwiener, Markus, Tesch, Hans, Schneeweiss, Andreas, Fehm, Tanja N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805215/
https://www.ncbi.nlm.nih.gov/pubmed/31656319
http://dx.doi.org/10.1055/a-1001-9952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805215/
https://www.ncbi.nlm.nih.gov/pubmed/31656319
http://dx.doi.org/10.1055/a-1001-9952

Ejemplares similares